Daniel K. Spiegelman, Director: Kyverna Therapeutics KYTX Planned sale · Filed 03/31

Trade details

Type: Planned sale notice
Stock: Kyverna Therapeutics KYTX
Person: Daniel K. SpiegelmanDirector
Planned sale date: 26/03/31
Filed: 26/03/31

$140.4K to be sold

Kyverna Therapeutics trades, last 26 weeks

What else happened in Kyverna Therapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Daniel K. Spiegelman's recent trades

Daniel K. SpiegelmanDirector
Planned saleKyverna Therapeutics
Planned sale
Kyverna Therapeutics
KYTX
$162.6K
17,578 sh
$162.6K
Filed 04/07
Traded 04/07
Daniel K. SpiegelmanDirector
Sell10b5-1 planMyriad Genetics
Sell10b5-1 plan
Myriad Genetics
MYGN
$83.5K
3,788 sh
$83.5K
Filed 24/06/04
Traded 24/06/03
Daniel K. SpiegelmanDirector
Sell10b5-1 planMyriad Genetics
Sell10b5-1 plan
Myriad Genetics
MYGN
$83.5K
3,788 sh
$83.5K
Filed 24/06/04
Traded 24/06/04
Daniel K. SpiegelmanDirector
SellMyriad Genetics
Sell
Myriad Genetics
MYGN
$198.8K
8,638 sh
$198.8K
Filed 23/06/02
Traded 23/06/02